Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
0.5778
-0.0021 (-0.36%)
At close: Jul 21, 2025, 4:00 PM
0.5880
+0.0102 (1.77%)
After-hours: Jul 21, 2025, 8:00 PM EDT
Company Description
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.
It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners.
The company was founded in 1996 and is headquartered in Germantown, Maryland.
Senseonics Holdings, Inc.
| Country | United States |
| Founded | 1996 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 117 |
| CEO | Timothy Goodnow |
Contact Details
Address: 20451 Seneca Meadows Parkway Germantown, Maryland 20876-7005 United States | |
| Phone | 301 515 7260 |
| Website | senseonics.com |
Stock Details
| Ticker Symbol | SENS |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001616543 |
| CUSIP Number | 81727U105 |
| ISIN Number | US81727U1051 |
| Employer ID | 47-1210911 |
| SIC Code | 3823 |
Key Executives
| Name | Position |
|---|---|
| Dr. Timothy T. Goodnow Ph.D. | President, Chief Executive Officer and Director |
| Dr. Mukul Jain Ph.D. | Chief Operating Officer |
| Kenneth L. Horton J.D. | General Counsel and Corporate Development Advisor |
| Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer and Director |
| Frederick T. Sullivan CPA | Chief Financial Officer, Secretary and Treasurer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 2, 2025 | SD | Form - SD |
| May 29, 2025 | D | Notice of Exempt Offering of Securities |
| May 21, 2025 | 8-K | Current Report |
| May 19, 2025 | 8-K/A | [Amend] Current report |
| May 16, 2025 | 8-K | Current Report |
| May 16, 2025 | 424B5 | Filing |
| May 15, 2025 | 424B5 | Filing |
| May 15, 2025 | 8-K | Current Report |
| May 8, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |